Pills for treating hyperostosis

Abstract

The invention discloses pills for treating hyperostosis, and belongs to the field of Chinese medicaments. The active ingredients of the pills comprise the following raw materials in parts by weight: 50 to 60 parts of prepared rehmannia root, 50 to 60 parts of drynaria rhizome, 50 to 60 parts of suberect spatholobus stem, 50 to 60 parts of cistanche salsa, 45 to 55 parts of clematis root, 45 to 55 parts of frankincense, 40 to 50 parts of myrrh, 40 to 50 parts of astragalus root, 35 to 45 parts of Szechuan lovage rhizome, 35 to 45 parts of white peony root, 30 to 40 parts of parabarium micranthum, 30 to 40 parts of kadsura pepper stem, 25 to 35 parts of epimedium, 25 to 35 parts of rhizoma cibotii, 25 to 35 parts of safflower, 20 to 30 parts of dragon blood, 20 to 30 parts of eupolyphaga, 15 to 25 parts of wooly datchmanspipe herb, and 1 to 5 parts of nux vomica. By adopting a monarch and minister regulation method, coordinating medicinal properties, researching the root and the source and considering the root and the causes, the pills are prepared from common Chinese medicinal materials through a plurality of methods and are low in medicinal cost and fine in processing; and clinical use proves that the pills have a good treatment effect on the hyperostosis at the lumbar vertebra, the thoracic vertebra, the cervical vertebra and the leg and foot joints.

Description

Technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a pill for treating hyperosteogeny. Background technique [0002] Osteoarthritis is a difficult disease with a very high incidence in orthopedics. At present, acupuncture, massage, iontophoresis, pill dialysis, closed traction and other physical therapy methods are often used clinically, or conservative anti-inflammatory and pain-relieving drugs are used for treatment. These treatment methods can only relieve the patient's pain to a certain extent, but cannot eradicate the focus. Most of the existing traditional Chinese medicine prescriptions use some nourishing medicinal materials with high cost as ingredients, but because of the difficulty in grasping the medicinal properties of toxic medicinal materials such as nuxychonzi, their unique medicinal properties are often abandoned and not included in the prescription. [0003] The fundamental principle of the compatibi...

AI Technical Summary

Problems solved by technology

These treatments can only alleviate the patient's pain to a certain extent, but cannot eradicate the lesion.

The existing traditional Chinese medicine prescriptions mostly use nourishing medicinal materials with high cost as ingredients. However, due to the difficulty in grasping the medicinal properties of toxic medicinal materials such as Nuxebra chinensis, their unique medicinal properties are often abandoned and not included in the prescription.